Issue Information - Forthcoming Papers
Radiotherapy-related acute myeloid leukaemia with KMT2A amplification
Optic neuritis as an initial manifestation of human herpesvirus 6 reactivation after unrelated bone marrow transplantation
Towards an understanding of the biology and targeted treatment of paediatric relapsed acute lymphoblastic leukaemia
The evolution of T-cell depletion in haploidentical stem-cell transplantation
Chimeric Antigen Receptor (CAR) therapy for multiple myeloma
Relative frequency of non-Hodgkin lymphoma subtypes in selected centres in North Africa, the middle east and India: a review of 971 cases
Central nervous system involvement by Waldenström macroglobulinaemia (Bing-Neel syndrome): a multi-institutional retrospective study
Non-Hodgkin lymphoma in Southern Africa: review of 487 cases from The International Non-Hodgkin Lymphoma Classification Project
Outcomes following watchful waiting for stage II–IV follicular lymphoma patients in the modern era
Clonal architecture of CXCR4 WHIM-like mutations in Waldenström Macroglobulinaemia
A phase 1/2 study of carfilzomib in Japanese patients with relapsed and/or refractory multiple myeloma
Late mortality, secondary malignancy and hospitalisation in teenage and young adult survivors of Hodgkin lymphoma: report of the Childhood/Adolescent/Young Adult Cancer Survivors Research Program and the BC Cancer Agency Centre for Lymphoid Cancer
New cellular markers at diagnosis are associated with isolated central nervous system relapse in paediatric B-cell precursor acute lymphoblastic leukaemia
Ribosomal RNA analysis in the diagnosis of Diamond-Blackfan Anaemia
Frequency and prognostic value of resistance/intolerance to hydroxycarbamide in 890 patients with polycythaemia vera
Resveratrol preserves the function of human platelets stored for transfusion
MAPK8-mediated stabilization of SP1 is essential for RUNX1-RUNX1T1 – driven leukaemia
Novel protein C gene mutation in a compound heterozygote resulting in catastrophic thrombosis in early adulthood: diagnosis and long-term treatment with subcutaneous protein C concentrate
Impaired leucocyte activation is underlining the lower thrombotic risk of essential thrombocythaemia patients with CALR mutations as compared with those with the JAK2 mutation
The AKT1 isoform plays a dominant role in the survival and chemoresistance of chronic lymphocytic leukaemia cells
Small nucleolar RNA expression profiles refine the prognostic impact of IGHV mutational status on treatment-free survival in chronic lymphocytic leukaemia
CD33, not early precursor T-cell phenotype, is associated with adverse outcome in adult T-cell acute lymphoblastic leukaemia
John Goldman Fellowships for Future Science